254 related articles for article (PubMed ID: 17763917)
1. Esophagectomy--it's not just about mortality anymore: standardized perioperative clinical pathways improve outcomes in patients with esophageal cancer.
Low DE; Kunz S; Schembre D; Otero H; Malpass T; Hsi A; Song G; Hinke R; Kozarek RA
J Gastrointest Surg; 2007 Nov; 11(11):1395-402; discussion 1402. PubMed ID: 17763917
[TBL] [Abstract][Full Text] [Related]
2. Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma.
Swanson SJ; Batirel HF; Bueno R; Jaklitsch MT; Lukanich JM; Allred E; Mentzer SJ; Sugarbaker DJ
Ann Thorac Surg; 2001 Dec; 72(6):1918-24; discussion 1924-5. PubMed ID: 11789772
[TBL] [Abstract][Full Text] [Related]
3. Evolution of standardized clinical pathways: refining multidisciplinary care and process to improve outcomes of the surgical treatment of esophageal cancer.
Markar SR; Schmidt H; Kunz S; Bodnar A; Hubka M; Low DE
J Gastrointest Surg; 2014 Jul; 18(7):1238-46. PubMed ID: 24777435
[TBL] [Abstract][Full Text] [Related]
4. Robot-assisted transhiatal esophagectomy: a 3-year single-center experience.
Dunn DH; Johnson EM; Morphew JA; Dilworth HP; Krueger JL; Banerji N
Dis Esophagus; 2013; 26(2):159-66. PubMed ID: 22394116
[TBL] [Abstract][Full Text] [Related]
5. A preliminary experience with minimally invasive Ivor Lewis esophagectomy.
Tapias LF; Morse CR
Dis Esophagus; 2012 Jul; 25(5):449-55. PubMed ID: 21967644
[TBL] [Abstract][Full Text] [Related]
6. The implementation of minimally-invasive esophagectomy does not impact short-term outcome in a high-volume center.
Schwameis K; Ba-Ssalamah A; Wrba F; Birner P; Prager G; Hejna M; Schmid R; Asari R; Zacherl J; Schoppmann SF
Anticancer Res; 2013 May; 33(5):2085-91. PubMed ID: 23645759
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive esophagectomy: thoracoscopic esophageal mobilization for esophageal cancer with the patient in prone position.
Petri R; Zuccolo M; Brizzolari M; Rossit L; Rosignoli A; Durastante V; Petrin G; De Cecchis L; Sorrentino M
Surg Endosc; 2012 Apr; 26(4):1102-7. PubMed ID: 22042593
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
Malaisrie SC; Untch B; Aranha GV; Mohideen N; Hantel A; Pickleman J
Arch Surg; 2004 May; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment of Barrett's carcinoma. Correlations between morphologic findings and prognosis.
Lerut T; Coosemans W; Van Raemdonck D; Dillemans B; De Leyn P; Marnette JM; Geboes K
J Thorac Cardiovasc Surg; 1994 Apr; 107(4):1059-65; discussion 1065-6. PubMed ID: 8159027
[TBL] [Abstract][Full Text] [Related]
10. The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia.
Edwards MJ; Gable DR; Lentsch AB; Richardson JD
Ann Surg; 1996 May; 223(5):585-9; discussion 589-91. PubMed ID: 8651749
[TBL] [Abstract][Full Text] [Related]
11. Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? A propensity score-based analysis.
Wang S; Huang Y; Xie J; Zhuge L; Shao L; Xiang J; Zhang Y; Sun Y; Hu H; Chen S; Lerut T; Luketich JD; Zhang J; Chen H
Surg Endosc; 2018 Mar; 32(3):1441-1448. PubMed ID: 28916920
[TBL] [Abstract][Full Text] [Related]
12. Esophagogastrectomy for carcinoma of the esophagus and cardia: a comparison of findings and results after standard resection in three consecutive eight-year intervals with improved staging criteria.
Ellis FH; Heatley GJ; Krasna MJ; Williamson WA; Balogh K
J Thorac Cardiovasc Surg; 1997 May; 113(5):836-46; discussion 846-8. PubMed ID: 9159617
[TBL] [Abstract][Full Text] [Related]
13. [Progress in oncological visceral surgery--esophageal carcinoma].
Siewert JR; Stein HJ
Kongressbd Dtsch Ges Chir Kongr; 2001; 118():44-9. PubMed ID: 11824293
[TBL] [Abstract][Full Text] [Related]
14. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy.
Bartel MJ; Wallace TM; Gomez-Esquivel RD; Raimondo M; Wolfsen HC; Woodward TA; Wallace MB
Gastrointest Endosc; 2017 Aug; 86(2):292-298. PubMed ID: 27889544
[TBL] [Abstract][Full Text] [Related]
15. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy.
Heitmiller RF; Redmond M; Hamilton SR
Ann Surg; 1996 Jul; 224(1):66-71. PubMed ID: 8678620
[TBL] [Abstract][Full Text] [Related]
16. Complete Barrett's eradication endoscopic mucosal resection: an effective treatment modality for high-grade dysplasia and intramucosal carcinoma--an American single-center experience.
Chennat J; Konda VJ; Ross AS; de Tejada AH; Noffsinger A; Hart J; Lin S; Ferguson MK; Posner MC; Waxman I
Am J Gastroenterol; 2009 Nov; 104(11):2684-92. PubMed ID: 19690526
[TBL] [Abstract][Full Text] [Related]
17. [Esophageal carcinoma].
Siewert JR
Chirurg; 2007 May; 78(5):475-84; quiz 485. PubMed ID: 17447037
[TBL] [Abstract][Full Text] [Related]
18. Survival in esophageal high-grade dysplasia/adenocarcinoma post endoscopic resection.
Qumseya BJ; Panossian AM; Rizk C; Cangemi DJ; Wolfsen C; Raimondo M; Woodward TA; Wallace MB; Wolfsen HC
Dig Liver Dis; 2013 Dec; 45(12):1028-33. PubMed ID: 23938135
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
Pennathur A; Luketich JD; Landreneau RJ; Ward J; Christie NA; Gibson MK; Schuchert M; Cooper K; Land SR; Belani CP
Ann Thorac Surg; 2008 Jun; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
[TBL] [Abstract][Full Text] [Related]
20. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
